GbS Global Biopharma ("GbS"), the wholly-owned Canadian subsidiary of GB Sciences, Inc. (OTCQB:GBLX), is a plant-inspired research and biopharma drug development company. Our goal is to create patented formulations of plant-inspired, optimized therapeutic mixtures (OTM) for the prescription drug market to treat a variety of conditions. The 'plant-inspired' active ingredients in our OTM are synthetic homologues identical to the original plant compounds, but produced synthetically under cGMP manufacturing controls. GbS' novel drug discovery platform has yielded 5 issued US and 3 issued international patents, as well as 19 US and 40 international patent-pending applications. In our drug development pipeline, GbS has five preclinical stage programs, and our lead Parkinson’s disease therapeutic program is being prepared for a First-in-Man clinical trial. In addition to Parkinson's disease, Gb is developing therapeutics for chronic pain, COVID-related cytokine release syndrome (CRS), Mast Cell Activation Syndrome (MCAS), anxiety, depression, and heart failure. GbS' productive research and development network includes nine universities, several hospitals, and Contract Research Organizations.
View Top Employees from GbS Global Biopharma, Inc.Website | http://www.gbsglobalbiopharma.com |
Revenue | $2 million |
Employees | 1 (0 on RocketReach) |
Founded | 2018 |
Address | 200-900 Morrison Dr, Ottawa, Ontario K2H 8K7, CA |
Phone | (866) 721-0297 |
Technologies |
JavaScript,
HTML,
PHP
+7 more
(view full list)
|
Industry | Biotechnology Research, Drug Stores & Pharmacies, Retail |
Competitors | Amplia PharmaTek Inc., Canadian Journal of Biotechnology, ProMIS™ Neurosciences, Inc. |
SIC | SIC Code 51 Companies, SIC Code 512 Companies |
NAICS | NAICS Code 4242 Companies, NAICS Code 42 Companies, NAICS Code 42421 Companies, NAICS Code 424 Companies |
Looking for a particular GbS Global Biopharma, Inc. employee's phone or email?
The GbS Global Biopharma, Inc. annual revenue was $2 million in 2024.
GbS Global Biopharma, Inc. is based in Ottawa, Ontario.
The NAICS codes for GbS Global Biopharma, Inc. are [4242, 42, 42421, 424].
The SIC codes for GbS Global Biopharma, Inc. are [51, 512].